N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide

C27H25F5N8O2 — CID 176974631

IUPACN-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide
SMILESC/N=C1/c2c(nc(-c3c(C(F)(F)F)c(C)cc4[nH]ncc34)c(F)c2NC=O)OC[C@H](C)N1C(C)c1cc(F)cnc1N
InChIInChI=1S/C27H25F5N8O2/c1-11-5-17-16(8-37-39-17)18(20(11)27(30,31)32)23-21(29)22(36-10-41)19-25(34-4)40(12(2)9-42-26(19)38-23)13(3)15-6-14(28)7-35-24(15)33/h5-8,10,12-13H,9H2,1-4H3,(H2,33,35)(H,37,39)(H,36,38,41)/b34-25-/t12-,13?/m0/s1
InChIKeyMFASJOHOUUYPRC-ZKNNFMRFSA-N
MW588.54 g/mol
LogP5.00
Rot. Bonds5

About N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide

N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide (PubChem CID 176974631) has the molecular formula C27H25F5N8O2 and a molecular weight of 588.54 g/mol. Its IUPAC name is N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide.

Molecular Properties

Compound NameN-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide
PubChem CID176974631
Molecular FormulaC27H25F5N8O2
Molecular Weight588.54 g/mol
Exact Mass588.20
IUPAC NameN-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide
SMILESC/N=C1/c2c(nc(-c3c(C(F)(F)F)c(C)cc4[nH]ncc34)c(F)c2NC=O)OC[C@H](C)N1C(C)c1cc(F)cnc1N
InChIInChI=1S/C27H25F5N8O2/c1-11-5-17-16(8-37-39-17)18(20(11)27(30,31)32)23-21(29)22(36-10-41)19-25(34-4)40(12(2)9-42-26(19)38-23)13(3)15-6-14(28)7-35-24(15)33/h5-8,10,12-13H,9H2,1-4H3,(H2,33,35)(H,37,39)(H,36,38,41)/b34-25-/t12-,13?/m0/s1
InChIKeyMFASJOHOUUYPRC-ZKNNFMRFSA-N
XLogP5.00
TPSA134.41 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500588.54
LogP ≤ 55.00
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide?
The IUPAC name of N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide (CID 176974631) is N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide.
What is the SMILES notation for N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide?
The canonical SMILES for N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide is C/N=C1/c2c(nc(-c3c(C(F)(F)F)c(C)cc4[nH]ncc34)c(F)c2NC=O)OC[C@H](C)N1C(C)c1cc(F)cnc1N.
What is the InChIKey of N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide?
The InChIKey is MFASJOHOUUYPRC-ZKNNFMRFSA-N. The full InChI is InChI=1S/C27H25F5N8O2/c1-11-5-17-16(8-37-39-17)18(20(11)27(30,31)32)23-21(29)22(36-10-41)19-25(34-4)40(12(2)9-42-26(19)38-23)13(3)15-6-14(28)7-35-24(15)33/h5-8,10,12-13H,9H2,1-4H3,(H2,33,35)(H,37,39)(H,36,38,41)/b34-25-/t12-,13?/m0/s1.
What are the key properties of N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide?
N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide has a molecular weight of 588.54 g/mol, XLogP of 5.00, 5 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S)-4-[1-(2-amino-5-fluoro-3-pyridinyl)ethyl]-7-fluoro-3-methyl-5-methylimino-8-[6-methyl-5-(trifluoromethyl)-1H-indazol-4-yl]-2,3-dihydropyrido[3,2-f][1,4]oxazepin-6-yl]formamide is sourced from PubChem (CID 176974631), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).